scholarly article | Q13442814 |
P356 | DOI | 10.1016/0041-008X(65)90050-5 |
P8608 | Fatcat ID | release_6waw7opy5fajloqi2e3yypizse |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0041008X65900505?httpAccept=text/plain |
https://api.elsevier.com/content/article/PII:0041008X65900505?httpAccept=text/xml | ||
P698 | PubMed publication ID | 5839398 |
P2093 | author name string | Banks WF Jr | |
D. J. Sullivan | |||
W. F. Banks | |||
E. W. McChesney | |||
P2860 | cites work | Pitfalls in a Discovery: The Chronicle of Chloroquine * | Q34254657 |
STUDIES ON THE CHRONIC TOXICITY OF CHLOROQUINE (SN-7618) | Q35307420 | ||
OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE. | Q39838619 | ||
OBSERVATIONS ON EXPERIMENTAL CHLOROQUINE RETINOPATHY. | Q41943790 | ||
THE PATHOLOGY OF CHLOROQUINE RETINOPATHY. | Q41943979 | ||
HISTOPATHOLOGY OF CHLOROQUINE RETINAL TOXICITY. | Q41944165 | ||
PIGMENTATION FROM ANTIMALARIAL THERAPY. ITS POSSIBLE RELATIONSHIP TO THE OCULAR LESIONS. | Q41944408 | ||
Ocular abnormalities in patients treated with synthetic antimalarial drugs | Q76428819 | ||
Retinopathy following chloroquine therapy | Q78766793 | ||
On visual disturbances and eye changes in quinoline therapy of primary chronic articular rheumatism | Q78836545 | ||
Studies on the chemotherapy of the human malarias; of the human malarias the physiological disposition, antimalarial activity, and toxicity of several derivatives of 4-aminoquinoline | Q95783821 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacology | Q128406 |
albinism | Q81867 | ||
hydroxychloroquine | Q421094 | ||
chloroquine | Q422438 | ||
pigmentation | Q14863538 | ||
P304 | page(s) | 627-636 | |
P577 | publication date | 1965-07-01 | |
P1433 | published in | Toxicology and Applied Pharmacology | Q2446974 |
P1476 | title | Metabolism of chloroquine and hydroxychloroquine in albino and pigmented rats | |
P478 | volume | 7 |
Q42645380 | A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery |
Q41920381 | A new trick for an ancient drug: quinine dissociates antiphospholipid immune complexes |
Q41927799 | Analysis of chloroquine and metabolites directly from whole-body animal tissue sections by liquid extraction surface analysis (LESA) and tandem mass spectrometry |
Q39772563 | Antimalarials in the management of discoid and systemic lupus erythematosus |
Q33853468 | Antimalarials: unapproved uses or indications |
Q41933743 | Blood platelets and chloroquine |
Q88956497 | Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature |
Q41946459 | Chloroquine disposition in hypersensitive and non-hypersensitive subjects and its significance in chloroquine-induced pruritus |
Q41923517 | Dendritic cells treated with chloroquine modulate experimental autoimmune encephalomyelitis |
Q41917055 | Different effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cells |
Q37238136 | Drug disposition in the mammalian eye and brain: a comparison of mechanisms |
Q39608521 | Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome |
Q41941073 | Ocular Changes Induced by Long-Term Hydroxychloroquine (Plaquenil) Therapy |
Q33971717 | Ocular effects of chlorpromazine and oxypertine on beagle dogs |
Q55060972 | Ocular effects of the venom from the spitting cobra (Naja nigricollis). |
Q56806709 | Proceedings of the British Pharmacological Society. Clinical Pharmacology Section. 14-16 April 1993. Abstracts |
Q99552022 | Quantitative Fundus Autofluorescence in Systemic Chloroquine/Hydroxychloroquine Therapy |
Q38561490 | Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases |
Q41922480 | Tissue and blood concentrations of chloroquine following chronic administration in the rat |
Q41941274 | Tissue distribution of chloroquine, hydroxychloroquine, and desethylchloroquine in the rat |
Q72258102 | Tumor localizing agents III Radioiodinated quinoline derivatives |